M. Hebsgaard, P. Eriksen, I. Ramberg, C. von Buchwald
{"title":"Human Papillomavirus in Sinonasal Malignancies","authors":"M. Hebsgaard, P. Eriksen, I. Ramberg, C. von Buchwald","doi":"10.1007/s40136-023-00448-3","DOIUrl":"https://doi.org/10.1007/s40136-023-00448-3","url":null,"abstract":"","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":" ","pages":"1-8"},"PeriodicalIF":0.6,"publicationDate":"2023-03-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43994025","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"A Review of EXIT: Interventions for Neonatal Airway Rescue","authors":"S. Goh, C. Peled, Michael Kuo","doi":"10.1007/s40136-023-00442-9","DOIUrl":"https://doi.org/10.1007/s40136-023-00442-9","url":null,"abstract":"","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":"11 1","pages":"27-36"},"PeriodicalIF":0.6,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45844368","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emilie R. Lowell, J. Borders, Jordanna S Sevitz, Avery E Dakin, Danielle Brates, M. Troche
{"title":"A Primer on Hypotussic Cough: Mechanisms and Assessment","authors":"Emilie R. Lowell, J. Borders, Jordanna S Sevitz, Avery E Dakin, Danielle Brates, M. Troche","doi":"10.1007/s40136-023-00446-5","DOIUrl":"https://doi.org/10.1007/s40136-023-00446-5","url":null,"abstract":"","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":"11 1","pages":"182-191"},"PeriodicalIF":0.6,"publicationDate":"2023-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41862117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Dysphagia Advances in Head and Neck Cancer.","authors":"J M Patterson, M Lawton","doi":"10.1007/s40136-023-00445-6","DOIUrl":"10.1007/s40136-023-00445-6","url":null,"abstract":"<p><strong>Purpose of review: </strong>This review summarises the current literature regarding head and neck cancer-associated dysphagia. Up-to-date evidence for dysphagia outcome measurement for this population is provided, in addition to recent innovations that aim to prevent, reduce or remediate the common and debilitating side effects of treatment.</p><p><strong>Recent findings: </strong>Both patient-reported outcomes and clinical measures are necessary to capture the multi-dimensional nature of swallowing. A minimally important difference in scores has been calculated for some of these measures, to aid interpretation and powering of clinical trials. The number of dysphagia-related trials has increased, predominantly investigating optimal treatment for oropharyngeal HPV-positive disease, and speech and language pathology interventions using an impairment-based approach.</p><p><strong>Summary: </strong>Although substantial progress has been made, further work is necessary to establish a consensus over outcome measures. Modifying treatments may improve outcomes. Several trials are underway to establish the effectiveness of speech and language pathology dysphagia interventions.</p>","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":" ","pages":"1-8"},"PeriodicalIF":0.6,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930077/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10755721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Office-Based Evaluation and Management of Dysphagia in Otolaryngology","authors":"A. Rameau, Gregory Postma, P. Belafsky","doi":"10.1007/s40136-023-00439-4","DOIUrl":"https://doi.org/10.1007/s40136-023-00439-4","url":null,"abstract":"","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":"11 1","pages":"9-18"},"PeriodicalIF":0.6,"publicationDate":"2023-02-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49412064","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Parosmia and Phantosmia: Managing Quality Disorders.","authors":"Aytug Altundag","doi":"10.1007/s40136-023-00441-w","DOIUrl":"https://doi.org/10.1007/s40136-023-00441-w","url":null,"abstract":"<p><strong>Purpose of review: </strong>The purpose of this review was to summarize the current knowledge on parosmia and phantosmia and introduce support and treatment algorithms for the two qualitative olfactory disorders.</p><p><strong>Recent findings: </strong>Recent literature regarding parosmia has revealed that patients with the disorder are mainly triggered by certain substances, including thiols and pyrazines. In 2015, the existing \"olfactory training\" regimen was improved to more effectively treat post-infectious olfactory loss and was named \"modified olfactory training\" (MOT). It was also found in 2022 that MOT is also effective against COVID-19-induced parosmia.</p><p><strong>Summary: </strong>Parosmia, the distortion of smells, is a symptom in qualitative olfactory disorders that severely affects patients' mental well-being and enjoyment of their everyday lives. The condition was first documented in 1895 and can affect up to 5% of the general population. Etiologies of parosmia include sinonasal diseases, viruses, surgeries, traumatic brain injury, neurological and psychiatric conditions, toxic chemicals, and medications. Parosmia has seen a surge in cases since the onset of the COVID-19 pandemic and is linked to changes in brain structure following an infection. The evaluation of the symptom is done using surveys, smell identification tests, fMRI, MRI, PET/CT, and gas chromatography. Treatment for parosmia can vary in duration, which makes it essential to focus not only on helping the patients regain normosmia, but also on supporting the patient through the recovery journey. Parosmia should not be confused with phantosmia, in which the distortion of smells occurs in the absence of olfactory stimuli. The etiology of phantosmia can vary from infections and traumatic brain injury to psychiatric disorders like schizophrenia. Unlike parosmia, the treatment of phantosmia is less straightforward, with an emphasis on determining the etiology and providing symptomatic relief.</p>","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":"11 1","pages":"19-26"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880375/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9457417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Flora Yan, Lindsay G Cowell, Anna Tomkies, Andrew T Day
{"title":"Therapeutic Vaccination for HPV-Mediated Cancers.","authors":"Flora Yan, Lindsay G Cowell, Anna Tomkies, Andrew T Day","doi":"10.1007/s40136-023-00443-8","DOIUrl":"https://doi.org/10.1007/s40136-023-00443-8","url":null,"abstract":"<p><strong>Purpose of review: </strong>The goal of this narrative review is to educate clinicians regarding the foundational concepts, efficacy, and future directions of therapeutic vaccines for human papillomavirus (HPV)-mediated cancers.</p><p><strong>Recent findings: </strong>Therapeutic HPV vaccines deliver tumor antigens to stimulate an immune response to eliminate tumor cells. Vaccine antigen delivery platforms are diverse and include DNA, RNA, peptides, proteins, viral vectors, microbial vectors, and antigen-presenting cells. Randomized, controlled trials have demonstrated that therapeutic HPV vaccines are efficacious in patients with cervical intraepithelial neoplasia. In patients with HPV-mediated malignancies, evidence of efficacy is limited. However, numerous ongoing studies evaluating updated therapeutic HPV vaccines in combination with immune checkpoint inhibition and other therapies exhibit significant promise.</p><p><strong>Summary: </strong>Therapeutic vaccines for HPV-mediated malignancies retain a strong biological rationale, despite their limited efficacy to date. Investigators anticipate they will be most effectively used in combination with other regimens, such as immune checkpoint inhibition.</p>","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":"11 1","pages":"44-61"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9890440/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9091038","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
E M Garden, A Espehana, D Boak, N Gadi, C M Philpott
{"title":"Commentary on Patient Advocacy and Research Priorities in Olfactory and Gustatory Disorders.","authors":"E M Garden, A Espehana, D Boak, N Gadi, C M Philpott","doi":"10.1007/s40136-023-00444-7","DOIUrl":"https://doi.org/10.1007/s40136-023-00444-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>This paper outlines the challenges faced by people with smell and taste disorders (SATDs) and why patient advocacy is crucial in addressing these. It includes recent findings in identifying research priorities in SATDs.</p><p><strong>Recent findings: </strong>A recent Priority Setting Partnership (PSP) conducted with the James Lind Alliance (JLA) has been completed and the top 10 research priorities in SATDs determined. Fifth Sense, a UK charity, has been working alongside patient and healthcare professions to drive awareness, education and research in this area.</p><p><strong>Summary: </strong>Following the completion of the PSP, Fifth Sense have launched six Research Hubs to take forward these priorities and engage with researchers to carry out and deliver research that directly answers the questions raised by the results of the PSP. The six Research Hubs cover a different aspect of smell and taste disorders. Each hub is led by clinicians and researchers recognised for their expertise in their field, who will act as champions for their respective hub.</p>","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":"11 1","pages":"1-8"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9936105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9143904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Recent Updates of Immunotherapy for Allergic Rhinitis in Children.","authors":"Chih-Feng Lin, Yi-Tsen Lin, Chun-Kang Liao, Te-Huei Yeh","doi":"10.1007/s40136-023-00440-x","DOIUrl":"https://doi.org/10.1007/s40136-023-00440-x","url":null,"abstract":"<p><strong>Purpose of review: </strong>Allergen immunotherapy (AIT) is a novel treatment approach with disease-modifying and preventative benefits that are not shared with other strategies for treating allergic illnesses. It has been demonstrated to be safe and effective in children. This review provides the most recent information on AIT in children as well as any pertinent updates.</p><p><strong>Recent findings: </strong>Although there is not a standard way to begin AIT, there are clear indications for AIT. Each case needs to be evaluated on its own by weighing the pros and downsides. AIT has been proven to significantly improve symptoms and quality of life in children with allergic illness, reduce medication use, stop the development of new allergen sensitizations, and stop the progression of allergic rhinitis to asthma. Novel approaches are under investigation to overcome some known AIT disadvantages.</p><p><strong>Summary: </strong>This review provides a thorough summary of the most recent research and updates on AIT in children.</p>","PeriodicalId":36165,"journal":{"name":"Current Otorhinolaryngology Reports","volume":"11 1","pages":"37-43"},"PeriodicalIF":0.6,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9088280","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
